학술논문
P1.01-001 Depth of Target Lesion Response to Brigatinib and Its Association With Outcomes in Patients With ALK+ NSCLC in the ALTA Trial
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S1892-S1892
Subject
Language
ISSN
1556-0864